A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients

NCT05590650 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasm
Chemoradiotherapy

Interventions

DRUG: SZKJT(San-Zhong-Kui-Jian-Tang)

Sponsor

China Medical University Hospital